Cargando…

ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma

BACKGROUND: ARL9 is a newly identified member of the ARF family, and the clinical significance of ARL9 in colon adenocarcinoma is unknown. In this study, we aimed to explore the expression of ARL9 mRNA in colon adenocarcinoma, and its effect on the prognosis of patients with colon adenocarcinoma. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hai-deng, Jin, Xiu-xiu, Gu, Bin-bin, Yu-Zhang, Li, Dan, Yan, Ling-ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951453/ https://www.ncbi.nlm.nih.gov/pubmed/36823542 http://dx.doi.org/10.1186/s12876-023-02677-8

Ejemplares similares

ARL11 correlates with the immunosuppression and poor prognosis in breast cancer: A comprehensive bioinformatics analysis of ARL family members
por: Xie, Ning, et al.
Publicado: (2022)

Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma
por: Niu, Cong, et al.
Publicado: (2022)

FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
por: Yu, Yilin, et al.
Publicado: (2021)

SKA1/2/3 serves as a biomarker for poor prognosis in human lung adenocarcinoma
por: Chen, Cheng, et al.
Publicado: (2020)

CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis
por: Yu, Senlong, et al.
Publicado: (2023)

TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma
por: Gao, Wen, et al.
Publicado: (2022)

SKA3 Serves as a Biomarker for Poor Prognosis in Kidney Renal Papillary Cell Carcinoma
por: Feng, Dechao, et al.
Publicado: (2021)

The small GTPases ARL-13 and ARL-3 coordinate intraflagellar transport and ciliogenesis
por: Li, Yujie, et al.
Publicado: (2010)

Upregulation of PD-L1 predicts poor prognosis and is associated with miR-191-5p dysregulation in colon adenocarcinoma
por: Chen, Xiao-Yu, et al.
Publicado: (2018)

BRCA1/2 Serves as a Biomarker for Poor Prognosis in Breast Carcinoma
por: Jin, Tong Yi, et al.
Publicado: (2022)

GTP-binding of ARL-3 is activated by ARL-13 as a GEF and stabilized by UNC-119
por: Zhang, Qing, et al.
Publicado: (2016)

CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma
por: Tan, Jianlong, et al.
Publicado: (2022)

Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma
por: Zhong, Yonglong, et al.
Publicado: (2015)

Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma
por: Lu, Guojun, et al.
Publicado: (2021)

PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma
por: Ge, Ouyang, et al.
Publicado: (2021)

The Upregulation of GSTO2 is Associated with Colon Cancer Progression and a Poor Prognosis
por: Peng, Xingyu, et al.
Publicado: (2023)

Tumor stroma Siglec15 expression is a poor prognosis predictor in colon adenocarcinoma
por: Zhan, Weixiang, et al.
Publicado: (2023)

Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinoma
por: Wu, Moxin, et al.
Publicado: (2020)

GPC1 Is Associated with Poor Prognosis and Treg Infiltration in Colon Adenocarcinoma
por: Liu, Ying, et al.
Publicado: (2022)

LncRNAs serve as novel biomarkers for diagnosis and prognosis of childhood ALL
por: Huang, Xuanmei, et al.
Publicado: (2021)

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)

Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma
por: Liu, Wenting, et al.
Publicado: (2021)

Upregulation of nectin-4 is associated with ITGB1 and vasculogenic mimicry and may serve as a predictor of poor prognosis in colorectal cancer
por: Zhang, Jinxiu, et al.
Publicado: (2019)

OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer
por: Zhou, Yi, et al.
Publicado: (2014)

Arl15 upregulates the TGFβ family signaling by promoting the assembly of the Smad-complex
por: Shi, Meng, et al.
Publicado: (2022)

Upregulation of ADAM12 Is Associated With a Poor Survival and Immune Cell Infiltration in Colon Adenocarcinoma
por: Huang, Zigao, et al.
Publicado: (2021)

Upregulation of MAGEA4 correlates with poor prognosis in patients with early stage of esophageal squamous cell carcinoma
por: Tang, Wei-Wei, et al.
Publicado: (2016)

ARL3 is downregulated and acts as a prognostic biomarker in glioma
por: Wang, Yulin, et al.
Publicado: (2019)

JAK3 and TYK2 Serve as Prognostic Biomarkers and Are Associated with Immune Infiltration in Stomach Adenocarcinoma
por: Meng, Lingkai, et al.
Publicado: (2020)

Upregulation of CISD2 augments ROS homeostasis and contributes to tumorigenesis and poor prognosis of lung adenocarcinoma
por: Li, Shih-Miao, et al.
Publicado: (2017)

Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma
por: Zhang, Yalu, et al.
Publicado: (2021)

Upregulated expression of G9a is correlated with poor prognosis of gastric cancer patients
por: Zhang, Chi, et al.
Publicado: (2019)

CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma
por: Wang, Xueying, et al.
Publicado: (2022)

IGFBP5 is Upregulated and Associated with Poor Prognosis in Colorectal Cancer
por: Deng, Yu, et al.
Publicado: (2022)

Prognostic significance of ARL9 and its methylation in low-grade glioma
por: Tan, Yutang, et al.
Publicado: (2020)

Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma
por: Yang, Mian, et al.
Publicado: (2022)

COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas
por: Gu, Sujie, et al.
Publicado: (2021)

Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study
por: Dong, Qian, et al.
Publicado: (2014)

COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer
por: Luo, Qi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bespgkbt8o1737plud931s9g38